gsk and save the children partnership how we’re helping · pdf filegsk and save the...

GSK and Save the Children partnership mid-term report 2

GSK and Save the Children partnership How we’re helping to save one million children’s lives

1 GSK and Save the Children partnership mid-term report

Aims of the partnershipLaunched in May 2013 with the ambition of helping to save one million children’s lives by:

Improving access to basic healthcare – prevention and treatment – where the need is greatest

Training and equipping health workers in the poorest communities

Developing child-friendly medicines with the potential to help save more lives

Working at local and global levels to call for stronger child health policies

“ The GSK and Save the Children partnership is an important example of the way the private and NGO sectors can collaborate for the benefit of the poorest people in the world. The challenges of improving health globally and achieving the Sustainable Development Goals’ ambition of leaving nobody behind are massive. Progress at the scale that is needed can only be achieved by combining the skills and efforts of all sectors to multiply the impact that can be achieved by each alone. This partnership is pointing the way.”

Lord Nigel Crisp Co-Chair of the All-Party Parliamentary Group on Global Health

An ambitious partnership

In late 2015, two and a half years into the partnership, GSK and Save the Children carried out a comprehensive ‘Mid-Term Review’ process. This entailed qualitative and quantitative assessments, including interviews with 29 people from both organisations, with the aim of understanding the successes, challenges, opportunities and risks encountered to date; and informing the future of the partnership. The figures and information contained within this document are informed by the Mid Term Review process and were accurate as of November 2015.


The partnership at a glance

Working together in

37 countries

TwoSignature Programmes* up and running in the Democratic Republic of Congo and Kenya

Over 125,600 children treated for malaria, pneumonia or diarrhoea

Over 108,400 children helped by GSK and Save the Children during and after emergencies

One simple ingredient, chlorhexidine, reformulated to save newborn babies’ lives

3.6 millionpeople including 1.3 million children directly reached by the partnership

Over £1.8 millionraised to date by GSK employees from over 70 countries, with every £1 matched by GSK

Over 23,900 children fully immunised

Over 10,600 health workers trained

* Save the Children’s world class programmes which employ a suite of innovative interventions and best practice approaches, aim to generate evidence and learning and can be replicated at scale.


Our achievements so far

The partnership is progressing towards achieving its ambition of helping to save one million children’s lives.

Strengthening health systems and infrastructure, including training health workers in Guinea, Liberia and Sierra Leone – the three countries affected by the Ebola outbreak in West Africa in 2014.

Two Signature Programmes – providing measurable results and evidence to help accelerate progress towards improving children’s lives – are underway. They have reached directly and indirectly: over 249,700 children in the Democratic Republic of Congo (DRC) and over 50,800 children in Kenya, with critical health interventions such as vaccinations, de-worming, and treatment for diseases and illnesses such as malaria, pneumonia and diarrhoea.

Investment in training and supporting health workers through programmes in 16 countries which are directly reaching children with vaccinations, treatment for pneumonia, diarrhoea and malaria, and screenings for malnutrition.

Reformulating chlorhexidine, an antiseptic ingredient in a GSK mouthwash, into a gel to help prevent umbilical cord infections which can lead to neonatal sepsis, a cause of newborn deaths worldwide.

Over 1 million children have been screened or treated for malnutrition.


What started as the vision of two CEOs from very different organisations, has now evolved into a successful global partnership that is helping to save children’s lives

Creating the groundbreaking Healthcare Innovation Award scheme which has recognised and invested in innovations in healthcare to make a positive impact on vulnerable children. 13 winning applicants have now shared a cash donation award of US$3m since 2013, to help them to advance their initiatives.

Over £1.8 million raised by GSK employees in 70 countries, and then matched by GSK. The business has also provided 45 skilled volunteers on 3-6 month assignments, supporting over 30 of Save the Children’s local and regional programmes worldwide.

The partnership’s united voice is advocating for Universal Health Coverage (UHC) at global and national levels. In April 2016, Burkina Faso announced free healthcare for children under five and pregnant women. Our partnership provided additional funds to support this advocacy work at critical periods to encourage this legislation to be passed. GSK has led the pharmaceutical industry to support UHC.

Supporting 12 humanitarian crisis appeals and emergency response activities in over 11 countries across the globe where Save the Children is delivering life-saving food, water, healthcare, protection and education to children in desperate need.

The relationship between the two partners continues to strengthen and grow – a willingness to adapt and learn from one another is the driving force behind its success

Our achievements so far continued


Learning through partnership

Lessons from our first three years of partnership can be grouped under three key themes – Scope, Scale and Sustainability, and Knowledge and Information. During the next two years of the partnership, this insight will inform the way forward.

Scope

Be flexible and open to change

• The GSK and Save the Children partnership is managed through workstreams, with relevant counterparts from both organisations. At launch, five workstreams were put in place – this has now risen to 10. This increase is a reflection of a deeper understanding of the two organisations priorities and a resulting identification of new shared goals.

• The impact of the ‘emergency response’ workstream, which was established less a year ago, illustrates the benefits that can be released efficiently and effectively through a relationship built on a greater understanding of each partner’s priorities and strengths.

Future action / considerations:

• Continued care must be taken to ensure that focus remains on generating impact for children, and that any new undertaking truly enhances and in no way dilutes this focus.

Scale and sustainability

Build on existing strengths and expertise for greater impact

• The partnership’s achievements in training healthcare workers demonstrate that impact at scale can be achieved more quickly through supplementing investments in existing programmes, rather than starting new initiatives from scratch.

• Leveraging the skills of employees and sharing expertise between organisations (particularly through initiatives such as employee volunteering programmes) can improve practices and capabilities, and lead to a deeper understanding of each partner organisation.


• Understandably in the initial phase, the partnership has focused more on delivery and less on sustainability of programmes and impact. This is something the partnership is keen to address in the next phase. In particular it has been identified that greater alignment on joint advocacy activity is needed.

Knowledge and information

Don’t underestimate the challenges of monitoring and evaluation (M&E) and the power of communication

• The resource needed for M&E was underestimated at the start of the partnership and resourcing issues in certain workstreams have, at times, hampered progress.

• Don’t underestimate the power of good internal communications in both organisations, in order to maintain buy-in and enthusiasm for the partnership.


• The partnership is committed to addressing M&E needs in the next phase and has established a new workstream dedicated to this. In particular, there is the recognition that more attention needs to be given to developing metrics to assess the business impact of partnership activities.

• Both organisations are focused on improving communications – ensuring that the impact and the stories of the partnership are shared more widely.


The partnership supports two Signature Programmes, one in the Democratic Republic of Congo (DRC), the second in Kenya, to tackle severe challenges in the supply of, and demand for, effective healthcare for mothers and their babies. Through these programmes we aim to generate evidence and learning that can be replicated at scale. Together, we are combining our efforts to deliver interventions such as upgrading health centres, training and equipping community health workers, and giving families and communities access to healthcare provision and services. These programmes were created in conjunction with the respective national Ministries of Health, increasing the likelihood that the model will continue locally and be scaled up at a national level’.

Case study

Breaking down the barriers for mums and children

Photo: Colin Crowley/Save the Children

“ In July 2014 we launched our programme through Kenya’s Ministry of Health to improve access to healthcare for pregnant women. I strongly believe that there are African solutions to Africa’s problems and the programme in Kenya is a good start.”

Dr Angela Muriuki, Head of Child Survival, Save the Children Kenya


Refugee families wait at a temporary camp in Röszke, Hungary before continuing their desperate journey. In situations like this, where no health system exists, or fails to function properly, children are at risk of missing out on the most basic care and services – food, water, shelter and primary healthcare. From Nepal to Sierra Leone, and Syria to Hungary, our partnership has helped children and families at their time of greatest need through humanitarian response activities, and has enhanced both organisation’s speed and ability to respond to crises.

When an emergency strikes – earthquake, flood or outbreak of conflict – there’s no time to waste. Save the Children’s Emergency Health Unit, seed funded by GSK, gets help to wherever it’s needed most, and fast. Within just 72 hours of a disaster, a team of specialist health workers is primed to fly out, set up and start delivering basic healthcare to save children’s lives.

During the Ebola crisis we scaled up our presence through GSK’s existing health worker training programmes in affected countries, and GSK deployed a bench scientist to Save the Children’s treatment centre in Sierra Leone.

Case study

When disaster strikes – Humanitarian Response through partnership

Photo: Jonathan Hyams/Save the Children


Realising the benefits of partnershipThe partnership’s operational principle is based on a shared value approach, that seeks to create measurable value for businesses, communities and wider society.

The purpose of our shared value partnership – to help save one million children’s lives by tackling preventable mortality in children under five – aligns with Sustainable Development Goals:

Good Health and Wellbeing

Partnerships for the Goals

From the outset of the collaboration, GSK and Save the Children established themselves as equal partners in the belief that the potential impact of working together would exceed what could be accomplished by either alone. In addition to the ‘on the ground’ impact of the partnership activities, by working in an open and collaborative way both organisations have also realised organisational benefits, including: • Insight into ways to improve access

to medicines in hard to reach locations

• Sharing Save the Children’s on the ground knowledge and insight into innovations needed to support access to quality healthcare in remote communities

• Supporting the creation of stronger health systems and improved infrastructure, which in turn creates long-term opportunities for all stakeholders including GSK

• Enhancing Save the Children’s expertise by accessing GSK know-how and skills through the GSK Pulse Volunteer Programme in a variety of areas from supply chain and logistics to change management

• Introducing new capabilities to Save the Children such as change management methodologies provided through GSK training and expertise

• Inspiring and engaging GSK’s global workforce, helping the company to retain and attract talentThe purpose of our shared

value partnership – to help save one million children’s lives by tackling preventable mortality in children under five – aligns with Sustainable Development Goals:

Good Health and Wellbeing

Partnerships for the Goals

3

17

Neonatal sepsis, a bacterial blood stream infection, kills 400,000 newborns a year in developing countries. The transformation of an everyday antiseptic into a medicine, with the aim of saving newborns in the world’s poorest countries, is a key milestone in the GSK and Save the Children Partnership.

Together, we have developed a gel which is a reformulation of chlorhexidine, an antiseptic used in a GSK mouthwash, for the prevention of umbilical cord infections that could lead to neonatal sepsis.

Combining GSK’s science, regulatory and manufacturing expertise with Save the Children’s insights and expertise in reaching marginalised children and families, the gel has been specifically designed for remote communities. It is heat-stable, to endure long hot journeys without need for refrigeration, and is in single-use tear-open sachets so it can be easily administered by health workers and mothers in the communities who most need it.

In April 2016, the European regulators (EMA) granted a positive scientific opinion for the gel, an important step towards making it available in the poorest countries, demonstrating tangible progress against our partnership’s mission.

GSK will next register the gel with local regulatory authorities in countries with regions of moderate-high neonatal mortality rates and a need for it. If approved in these countries, the gel will be offered at a not-for-profit price and GSK will share its manufacturing know-how to enable interested local companies to make the product themselves.

Case study

From mouthwash to potentially life-saving medicine

Photo: Colin Crowley/Save the Children

GSK and Save the Children are currently working together on programmes in

37 countries worldwide

Photo credits Front cover: Ivy Lahon/ Save The Children. Page 1: (far left) David Wardell/Save the Children, (left) Martin Webb/Save the Children, (far right) Tanya Bindra/Save the Children. Page 3: (bottom left) Colin Crowley/Save the Children,(bottom right) Aubrey Wadey/Save the Children. Page 4: (top) Greg Funnell/Save the Children, (centre) Jonathan Hyams/Save the Children. Page 8: Tugela Ridley/Save the Children

About GSK

We are a science-led global healthcare company. We have three world-leading businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. We are committed to widening access to our products and working to make our products available to as many people as possible, no matter where they live in the world or what they can afford to pay.

We are on a mission to help people do more, feel better, live longer.

To find out more go to www.gsk.com

Tel: +44(0)20 8047 5000Email: [email protected]

About Save the Children

Save the Children believes every child deserves a future. In the UK and around the world, we work every day to give children a healthy start in life, the opportunity to learn and protection from harm. When crisis strikes, and children are most vulnerable, we are always among the first to respond and the last to leave. We ensure children’s unique needs are met and their voices are heard. We deliver lasting results for millions of children, including those hardest to reach. We do whatever it takes for children – every day and in times of crisis – transforming their lives and the future we share

To find out more go to www.savethechildren.org.uk

Tel: +44 (0)20 7012 6400Email: [email protected]

gsk and save the children partnership how we’re helping · pdf filegsk and save the...

Documents